BASSAM ARODAK
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OKLAHOMA CITY, OK NPI 1124138680
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OK Tandem Diabetes Care, Inc. All categories
General Payments — all program years on this page
$6,121.17
- Category: General Payments
- Program years: PY2018–2024
- Record count: 366
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,502.69 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,094.69 | 49 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400.00 | 1 |
| Education | $8.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tandem Diabetes Care, Inc. | $531.50 | 6 |
| Corcept Therapeutics | $178.43 | 9 |
| DEXCOM, INC. | $105.97 | 6 |
| Xeris Pharmaceuticals, Inc. | $100.85 | 5 |
| Lilly USA, LLC | $96.13 | 4 |
| SANOFI-AVENTIS U.S. LLC | $66.37 | 3 |
| Ascensia Diabetes Care US Inc. | $63.02 | 2 |
| Radius Health, Inc. | $56.49 | 2 |
| CeQur Corporation | $47.28 | 1 |
| Alexion Pharmaceuticals, Inc. | $42.86 | 2 |
| Antares Pharma, Inc. | $42.71 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.90 | 2 |
| Amgen Inc. | $31.13 | 2 |
| ABBVIE INC. | $23.89 | 1 |
| Abbott Laboratories | $23.27 | 1 |
| Novo Nordisk AS | $22.88 | 1 |
| CHIESI USA, INC. | $18.73 | 1 |
| Medtronic, Inc. | $16.28 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.